D
David G. Kornguth
Researcher at University of Texas MD Anderson Cancer Center
Publications - 14
Citations - 2596
David G. Kornguth is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiation therapy & Proton therapy. The author has an hindex of 9, co-authored 14 publications receiving 2282 citations. Previous affiliations of David G. Kornguth include University of Texas Health Science Center at Houston.
Papers
More filters
Journal ArticleDOI
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
Eric L. Chang,Jeffrey S. Wefel,Kenneth R. Hess,Pamela K. Allen,Frederick F. Lang,David G. Kornguth,Rebecca Arbuckle,J. Michael Swint,Almon S. Shiu,Moshe H. Maor,Christina A. Meyers +10 more
TL;DR: Patients treated with SRS plus WBRT were at a greater risk of a significant decline in learning and memory function by 4 months compared with the group that received SRS alone, and patients treatment with a combination of SRS and close clinical monitoring was recommended as the preferred treatment strategy.
Journal ArticleDOI
The risk of developing a second cancer after receiving craniospinal proton irradiation.
Wayne D. Newhauser,Wayne D. Newhauser,Jonas D. Fontenot,Jonas D. Fontenot,Anita Mahajan,David G. Kornguth,Marilyn Stovall,Y Zheng,Phillip J. Taddei,Dragan Mirkovic,Radhe Mohan,James D. Cox,Shiao Y. Woo +12 more
TL;DR: Simulations revealed that both passively scattered and scanned-beam proton therapies confer significantly lower risks of second cancers than 6 MV conventional and intensity-modulated photon therapies.
Journal ArticleDOI
Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams
Phillip J. Taddei,Dragan Mirkovic,Jonas D. Fontenot,Annelise Giebeler,Y Zheng,David G. Kornguth,Radhe Mohan,Wayne D. Newhauser +7 more
TL;DR: A baseline estimate of the stray radiation dose and corresponding risk for a pediatric patient undergoing proton CSI is established and the suitability of passively-scattered proton beams for the treatment of central nervous system tumors in pediatric patients is supported.
Journal ArticleDOI
Multimodality treatment of osteosarcoma: radiation in a high-risk cohort.
Anita Mahajan,Shiao Y. Woo,David G. Kornguth,Dennis P.M. Hughes,Winston W. Huh,Eric L. Chang,Cynthia E. Herzog,Christopher E. Pelloski,Pete Anderson +8 more
TL;DR: Chemotherapy during radiation and/or bone‐seeking radioisotope therapy (153‐samarium; 1 mCi/kg) during radiation may improve osteosarcoma cancer control.
Journal ArticleDOI
Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiation
Phillip J. Taddei,Anita Mahajan,Dragan Mirkovic,Rui Zhang,Annelise Giebeler,David G. Kornguth,Mark C. Harvey,Shiao Y. Woo,Wayne D. Newhauser +8 more
TL;DR: It is suggested that the risks of SMN incidence and mortality from neutrons may be greater for girls than for boys treated with proton CSI.